[1] VILLAR J, BLANCO J, KACMAREK RM. Current incidence and outcome of the acute respiratory distress syndrome. Curr Opin Crit Care. 2016; 22(1): 1-6.
[2] 强勇,梁贵友,余丽梅,等.人羊膜间充质干细胞移植减轻体外循环再灌注肺损伤[J].中国组织工程研究,2016,20(1): 70-77.
[3] GALIPEAU J, SENSÉBÉ L. Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities. Cell Stem Cell. 2018; 22(6):824-833.
[4] QIANG Y, LIANG G, YU L. Human amniotic mesenchymal stem cells alleviate lung injury induced by ischemia and reperfusion after cardiopulmonary bypass in dogs. Lab Invest. 2016;96(5):537-546.
[5] DOMINICI M, LE BLANC K, MUELLER I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8(4):315-317.
[6] ZHANG J, SHAO Y, HE D, et al. Evidence that bone marrow-derived mesenchymal stem cells reduce epithelial permeability following phosgene-induced acute lung injury via activation of wnt3a protein-induced canonical wnt/β-catenin signaling. Inhal Toxicol. 2016;28(12):572-579.
[7] LI JW, WEI L, HAN Z, et al. Mesenchymal stromal cells-derived exosomes alleviate ischemia/reperfusion injury in mouse lung by transporting anti-apoptotic miR-21-5p. Eur J Pharmacol. 2019;852: 68-76.
[8] ENGELMAN JA, LUO J, CANTLEY LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet. 2006;7(8):606-619.
[9] LORUSSO PM. Inhibition of the PI3K/AKT/mTOR Pathway in Solid Tumors. J Clin Oncol. 2016;34(31):3803-3815.
[10] CHU H, HAO W, CHENG Z, et al. Black carbon particles and ozone-oxidized black carbon particles induced lung damage in mice through an interleukin-33 dependent pathway. Sci Total Environ. 2018; 644:217-228.
[11] LI J, ZHOU J, ZHANG D, et al. Bone marrow-derived mesenchymal stem cells enhance autophagy via PI3K/AKT signalling to reduce the severity of ischaemia/reperfusion-induced lung injury. J Cell Mol Med. 2015;19(10):2341-2351.
[12] GHANTA S, TSOYI K, LIU X, et al. Mesenchymal Stromal Cells Deficient in Autophagy Proteins Are Susceptible to Oxidative Injury and Mitochondrial Dysfunction. Am J Respir Cell Mol Biol. 2017;56(3): 300-309.
[13] LI J, HUANG S, ZHANG J, et al. Mesenchymal stem cells ameliorate inflammatory cytokine-induced impairment of AT-II cells through a keratinocyte growth factor-dependent PI3K/Akt/mTOR signaling pathway. Mol Med Rep. 2016;13(5):3755-3762.
[14] LIN HY, XU L, XIE SS, et al. Mesenchymal stem cells suppress lung inflammation and airway remodeling in chronic asthma rat model via PI3K/Akt signaling pathway. Int J Clin Exp Pathol. 2015;8(8):8958-8967.
[15] KIM SY, LEE JH, KIM HJ, et al. Mesenchymal stem cell-conditioned media recovers lung fibroblasts from cigarette smoke-induced damage. Am J Physiol Lung Cell Mol Physiol.2012;302(9): L891-908.
[16] LI B, ZHANG H, ZENG M, et al. Bone marrow mesenchymal stem cells protect alveolar macrophages from lipopolysaccharide-induced apoptosis partially by inhibiting the Wnt/β-catenin pathway. Cell Biol Int. 2015;39(2):192-200.
[17] LIU AR, LIU L, CHEN S, et al. Activation of canonical wnt pathway promotes differentiation of mouse bone marrow-derived MSCs into type II alveolar epithelial cells, confers resistance to oxidative stress, and promotes their migration to injured lung tissue in vitro. J Cell Physiol. 2013;228(6):1270-1283.
[18] GAO P, YANG J, GAO X, et al. Salvianolic acid B improves bone marrow-derived mesenchymal stem cell differentiation into alveolar epithelial cells type I via Wnt signaling. Mol Med Rep. 2015;12(2): 1971-1976.
[19] CAI SX, LIU AR, CHEN S, et al. Activation of Wnt/β-catenin signalling promotes mesenchymal stem cells to repair injured alveolar epithelium induced by lipopolysaccharide in mice. Stem Cell Res Ther. 2015;6:65.
[20] WANG C, ZHU H, SUN Z, et al. Inhibition of Wnt/β-catenin signaling promotes epithelial differentiation of mesenchymal stem cells and repairs bleomycin-induced lung injury. Am J Physiol Cell Physiol. 2014; 307(3):C234-244.
[21] SUN J, CHEN J, CAO J, et al. IL-1β-stimulated β-catenin up-regulation promotes angiogenesis in human lung-derived mesenchymal stromal cells through a NF-κB-dependent microRNA-433 induction. Oncotarget. 2016;7(37):59429-59440.
[22] OECKINGHAUS A, GHOSH S. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol. 2009;1(4): a000034.
[23] WANG G, CAO K, LIU K, et al. Kynurenic acid, an IDO metabolite, controls TSG-6-mediated immunosuppression of human mesenchymal stem cells. Cell Death Differ. 2018;25(7):1209-1223.
[24] LI D, PAN X, ZHAO J, et al. Bone Marrow Mesenchymal Stem Cells Suppress Acute Lung Injury Induced by Lipopolysaccharide Through Inhibiting the TLR2, 4/NF-κB Pathway in Rats with Multiple Trauma. Shock. 2016;45(6):641-646.
[25] GUPTA N, SINHA R, KRASNODEMBSKAYA A, et al. The TLR4-PAR1 Axis Regulates Bone Marrow Mesenchymal Stromal Cell Survival and Therapeutic Capacity in Experimental Bacterial Pneumonia. Stem Cells. 2018;36(5):796-806.
[26] SU VY, LIN CS, HUNG SC, et al. Mesenchymal Stem Cell-Conditioned Medium Induces Neutrophil Apoptosis Associated with Inhibition of the NF-κB Pathway in Endotoxin-Induced Acute Lung Injury. Int J Mol Sci. 2019;20(9): E2208.
[27] MARTIRE A, BEDADA FB, UCHIDA S, et al. Mesenchymal stem cells attenuate inflammatory processes in the heart and lung via inhibition of TNF signaling. Basic Res Cardiol. 2016;111(5):54.
[28] MATTHAY MA, THOMPSON BT, READ EJ, et al. Therapeutic potential of mesenchymal stem cells for severe acute lung injury. Chest. 2010; 138(4): 965-972.
[29] XU S, LIU C, JI HL. Concise Review: Therapeutic Potential of the Mesenchymal Stem Cell Derived Secretome and Extracellular Vesicles for Radiation-Induced Lung Injury: Progress and Hypotheses. Stem Cells Transl Med. 2019;8(4):344-354.
[30] FINCH PW, RUBIN JS. Keratinocyte growth factor expression and activity in cancer: implications for use in patients with solid tumors. J Natl Cancer Inst. 2006;98(12):812-824.
[31] VADIJA R, MUSTYALA KK, NAMBIGARI N, et al. Homology modeling and virtual screening studies of FGF-7 protein-a structure-based approach to design new molecules against tumor angiogenesis. J Chem Biol. 2016;9(3):69-78.
[32] CURLEY GF, HAYES M, ANSARI B, et al. Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat. Thorax. 2012;67(6):496-501.
[33] YAO L, LIU CJ, LUO Q, et al. Protection against hyperoxia-induced lung fibrosis by KGF-induced MSCs mobilization in neonatal rats. Pediatr Transplant. 2013;17(7):676-682.
[34] YANG Y, CHEN QH, Liu AR, et al. Synergism of MSC-secreted HGF and VEGF in stabilising endothelial barrier function upon lipopolysaccharide stimulation via the Rac1 pathway. Stem Cell Res Ther. 2015;6:250.
[35] MEI Y, CHEN C, DONG H, et al. Treatment of Hyperoxia-Induced Lung Injury with Lung Mesenchymal Stem Cells in Mice. Stem Cells Int. 2018; 2018:5976519.
[36] LEEMAN KT, PESSINA P, LEE JH, et al. Mesenchymal Stem Cells Increase Alveolar Differentiation in Lung Progenitor Organoid Cultures. Sci Rep. 2019;9(1):6479.
[37] ZHU F, WANG J, QIU X, et al. Smoke inhalation injury repaired by a bone marrow-derived mesenchymal stem cell paracrine mechanism: Angiogenesis involving the Notch signaling pathway. J Trauma Acute Care Surg. 2015;78(3):565-572.
[38] MCNULTY K, JANES SM. Stem cells and pulmonary fibrosis: cause or cure. Proc Am Thorac Soc. 2012;9(3):164-171.
[39] PARK J, KIM S, LIM H, et al. Therapeutic effects of human mesenchymal stem cell microvesicles in an ex vivo perfused human lung injured with severe E. coli pneumonia. Thorax. 2019;74(1):43-50.
[40] LIU HM, LIU YT, ZHANG J, et al. Bone marrow mesenchymal stem cells ameliorate lung injury through anti-inflammatory and antibacterial effect in COPD mice. J Huazhong Univ Sci Technolog Med Sci. 2017;37(4): 496-504.
[41] MORRISON TJ, JACKSON MV, CUNNINGHAM EK, et al. Mesenchymal Stromal Cells Modulate Macrophages in Clinically Relevant Lung Injury Models by Extracellular Vesicle Mitochondrial Transfer. Am J Respir Crit Care Med. 2017;196(10):1275-1286.
[42] XU N, SHAO Y, YE K, et al. Mesenchymal stem cell-derived exosomes attenuate phosgene-induced acute lung injury in rats. Inhal Toxicol. 2019; 31(2):52-60.
[43] LI QC, LIANG Y, SU ZB. Prophylactic treatment with MSC-derived exosomes attenuates traumatic acute lung injury in rats. Am J Physiol Lung Cell Mol Physiol. 2019;316(6):L1107-L1117.
[44] ZHANG X, CHEN J, XUE M, et al. Overexpressing p130/E2F4 in mesenchymal stem cells facilitates the repair of injured alveolar epithelial cells in LPS-induced ARDS mice. Stem Cell Res Ther. 2019;10(1):74.
[45] LI L, DONG L, ZHANG J, et al. Mesenchymal stem cells with downregulated Hippo signaling attenuate lung injury in mice with lipopolysaccharide‑induced acute respiratory distress syndrome. Int J Mol Med. 2019;43(3): 1241-1252.
[46] HUANG Z, LIU H, ZHANG X, et al. Transcriptomic analysis of lung tissues after hUC-MSCs and FTY720 treatment of lipopolysaccharide- induced acute lung injury in mouse models. Int Immunopharmacol. 2018;63: 26-34.
[47] ZHANG X, GAO F, LI Q, et al. MSCs with ACE II gene affect apoptosis pathway of acute lung injury induced by bleomycin. Exp Lung Res. 2015;41(1):32-43.
[48] LUAN Y, ZHANG L, CHAO S, et al. Mesenchymal stem cells in combination with erythropoietin repair hyperoxia-induced alveoli dysplasia injury in neonatal mice via inhibition of TGF-β1 signaling. Oncotarget. 2016;7(30): 47082-47094.
[49] SUN C, ZHANG S, WANG J, et al. EPO enhances the protective effects of MSCs in experimental hyperoxia-induced neonatal mice by promoting angiogenesis. Aging (Albany NY). 2019;11(8):2477-2487.
[50] ROYCE SG, MAO W, LIM R, et al. iPSC- and mesenchymoangioblast- derived mesenchymal stem cells provide greater protection against experimental chronic allergic airways disease compared with a clinically used corticosteroid. FASEB J. 2019;33(5): 6402-6411.
[51] GUPTA N, NIZET V. Stabilization of Hypoxia-Inducible Factor-1 Alpha Augments the Therapeutic Capacity of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Pneumonia. Front Med (Lausanne). 2018;5:131.
[52] LI B, LI C, ZHU M, et al. Hypoxia-Induced Mesenchymal Stromal Cells Exhibit an Enhanced Therapeutic Effect on Radiation-Induced Lung Injury in Mice due to an Increased Proliferation Potential and Enhanced Antioxidant Ability. Cell Physiol Biochem. 2017;44(4):1295-1310.
[53] WILSON JG, LIU KD, ZHUO H, et al. Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. Lancet Respir Med. 2015;3(1):24-32.
|